New coding in the International Classification of Diseases, Ninth Revision, for children's interstitial lung disease

Chest

Volumn 142, Issue 3, 2012, Pages 774-780

  Popler, Jonathan ^a   Lesnick, Burton ^a   Dishop, Megan K ^b   Deterding, Robin R ^c  

^a Georgia Pediatric Pulmonology Associates   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID TRANSCRIPTION FACTOR 1;

CELL HYPERPLASIA; CHILD; CHILDREN INTERSTITIAL LUNG DISEASE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GLYCOGEN STORAGE DISEASE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG DISEASE; MORBIDITY; MORTALITY; NEUROSECRETORY CELL; PRIORITY JOURNAL; PULMONARY VEIN; RECOGNITION; REVIEW;

EID: 84865853242     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0492     Document Type: Article

References (60)

1. Deterding R. Evaluating infants and children with interstitial lung disease. Semin Respir Crit Care Med. 2007;28(3):333-341. (Pubitemid 46982064)
2. Deutsch GH, Young LR, Deterding RR, et al Pathology Cooperative Group; ChILD Research Co-operative. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176(11):1120-1128. (Pubitemid 350223758)
3. Langston C, Dishop MK. Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies. Pediatr Dev Pathol. 2009;12(6):421-437.
4. Centers for Medicare and Medicaid Services. ICD-9-CM. Centers for Medicare and Medicaid Services website. https://www.cms.gov/ ICD9ProviderDiagnosticCodes/. Accessed February 22, 2012.
5. Deterding RR, Fan LL, Morton R, Hay TC, Langston C. Persistent tachypnea of infancy (PTI) - a new entity. Pediatr Pulmonol. 2001;23(suppl 23):72-73. (Pubitemid 33021806)
6. Deterding RR, Pye C, Fan LL, Langston C. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol. 2005;40(2):157-165. (Pubitemid 41099432)
7. Brody AS. Imaging considerations: interstitial lung disease in children. Radiol Clin North Am. 2005;43(2):391-403. (Pubitemid 40292840)
8. Brody AS, Crotty EJ. Neuroendocrine cell hyperplasia of infancy (NEHI). Pediatr Radiol. 2006;36(12):1328. (Pubitemid 44920876)
9. Brody AS, Guillerman RP, Hay TC, et al. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. AJR Am J Roentgenol. 2010;194(1):238-244.
10. Kerby GS, Kopecky C, Wilcox SL, et al. Infant pulmonary function testing in children with neuroendocrine cell hyperplasia with and without lung biopsy [abstract]. Am J Respir Crit Care Med. 2009;179:A3671.
11. Dishop MK. Diagnostic pathology of diffuse lung disease in children. Pediatr Allergy Immunol Pulmonol. 2010;23(1):69-85.
12. Young LR, Brody AS, Inge TH, et al. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Chest. 2011;139(5):1060-1071.
13. Deterding, RR. Infants and young children with children's interstitial lung disease. Pediatr Allergy Immunol Pulmonol. 2010:23(1):25-31.
14. Popler J, Wagner BD, Accurso F, Deterding RR. Airway cytokine profiles in children's interstitial lung diseases [abstract]. Am J Respir Crit Care Med. 2010;181:A3316.
15. Deterding RR, Wolfson A, Harris JK, Walker J, Accurso FJ. Aptamer proteomic analysis of bronchoalveolar lavage fluid yields different protein signatures from children with children's interstitial lung disease, cystic fibrosis and disease controls [abstract]. Am J Respir Crit Care Med. 2010;181:A6722.
16. Doan ML, Elidemir O, Dishop MK, et al. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Thorax. 2009;64(8):677-681.
17. Popler J, Young LR, Deterding RR. Beyond infancy: persistence of chronic lung disease in neuroendocrine cell hyperplasia of infancy (NEHI) [abstract]. Am J Respir Crit Care Med. 2010;181:A6721.
18. Popler J, Gower WA, Mogayzel PJ Jr, et al. Familial neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol. 2010;45(8):749-755.
19. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta. 1998;1408(2-3):79-89. (Pubitemid 28517859)
20. Farrell PM, Avery ME. Hyaline membrane disease. Am Rev Respir Dis. 1975;111(5):657-688.
21. Nogee, LM. Genetic basis of children's interstitial lung disease. Pediatr Allergy Immunol Pulmonol. 2010:23(1):15-24.
22. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med. 1993;328(6):406-410. (Pubitemid 23042289)
23. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med. 2000;161(3 pt 1):973-981. (Pubitemid 30171760)
24. Somaschini M, Nogee LM, Sassi I, et al. Unexplained neonatal respiratory distress due to congenital surfactant deficiency. J Pediatr. 2007;150(6):649-653.
25. Tredano M, Griese M, de Blic J, et al. Analysis of 40 sporadic or familial neonatal and pediatric cases with severe unexplained respiratory distress: relationship to SFTPB. Am J Med Genet A. 2003;119A(3):324-339. (Pubitemid 37063863)
26. Hamvas A, Nogee LM, Mallory GB Jr, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr. 1997;130(2):231-239. (Pubitemid 27495158)
27. Palomar LM, Nogee LM, Sweet SC, Huddleston CB, Cole FS, Hamvas A. Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. J Pediatr. 2006;149(4):548-553. (Pubitemid 44468091)
28. Ballard PL, Nogee LM, Beers MF, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics. 1995;96(6):1046-1052.
29. Dunbar AE III, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res. 2000;48(3):275-282. (Pubitemid 30637324)
30. Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med. 2001;344(8):573-579. (Pubitemid 32167871)
31. Soraisham AS, Tierney AJ, Amin HJ. Neonatal respiratory failure associated with mutation in the surfactant protein C gene. J Perinatol. 2006;26(1):67-70. (Pubitemid 43135259)
32. Cameron HS, Somaschini M, Carrera P, et al. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr. 2005;146(3):370-375. (Pubitemid 40341748)
33. Nogee LM, Dunbar AE III, Wert S, Askin F, Hamvas A, Whitsett JA. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest. 2002;121(suppl 3):20S-21S. (Pubitemid 34248314)
34. Thomas AQ, Lane K, Phillips J III, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med. 2002;165(9):1322-1328. (Pubitemid 34461748)
35. Hamvas A, Nogee LM, White FV, et al. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol. 2004;30(6):771-776. (Pubitemid 38736899)
36. Abou Taam R, Jaubert F, Emond S, et al. Familial interstitial disease with I73T mutation: A mid-and long-term study. Pediatr Pulmonol. 2009;44(2):167-175.
37. Rosen DM, Waltz DA. Hydroxychloroquine and surfactant protein C deficiency. N Engl J Med. 2005;352(2):207-208.
38. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res. 2007;62(2):176-179. (Pubitemid 47205717)
39. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med. 2004;350(13):1296-1303. (Pubitemid 38375364)
40. Garmany TH, Moxley MA, White FV, et al. Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res. 2006;59(6):801-805. (Pubitemid 44297632)
41. Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008;63(4):366-373. (Pubitemid 351497952)
42. Yokota T, Matsumura Y, Ban N, Matsubayashi T, Inagaki N. Heterozygous ABCA3 mutation associated with non-fatal evolution of respiratory distress. Eur J Pediatr. 2008;167(6):691-693. (Pubitemid 351503490)
43. Young LR, Nogee LM, Barnett B, Panos RJ, Colby TV, Deutsch GH. Usual interstitial pneumonia in an adolescent with ABCA3 mutations. Chest. 2008;134(1):192-195. (Pubitemid 352008784)
44. Hamvas A, Nogee LM, Wegner DJ, et al. Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-B and ATP binding cassette, subfamily A, member 3 genes. J Pediatr. 2009;155(6):854-859.
45. Matsumura Y, Ban N, Inagaki N. Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2008;295(4):L698-L707.
46. Iwatani N, Mabe H, Devriendt K, Kodama M, Miike T. Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr. 2000;137(2):272-276. (Pubitemid 30659242)
47. Pohlenz J, Dumitrescu A, Zundel D, et al. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest. 2002;109(4):469-473. (Pubitemid 34171777)
48. Krude H, Schütz B, Biebermann H, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest. 2002;109(4):475-480. (Pubitemid 34171778)
49. Willemsen MA, Breedveld GJ, Wouda S, et al. Brain-Thyroid-Lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur J Pediatr. 2005;164(1):28-30. (Pubitemid 40110004)
50. Carré A, Szinnai G, Castanet M, et al. Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet. 2009;18(12):2266-2276.
51. Moya CM, Perez de Nanclares G, Castaño L, et al. Functional study of a novel single deletion in the TITF1/NKX2.1 homeobox gene that produces congenital hypothyroidism and benign chorea but not pulmonary distress. J Clin Endocrinol Metab. 2006;91(5):1832-1841.
52. Deterding RR, Dishop M, Uchida DA, et al. Thyroid transcription factor 1 gene abnormalities: an underrecognized cause of children's interstitial lung disease [abstract]. Am J Respir Crit Care Med. 2010;181:A6725.
53. Ferrara AM, De Michele G, Salvatore E, et al. A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. Thyroid. 2008;18(9):1005-1009.
54. Suzuki T, Maranda B, Sakagami T, et al. Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations. Eur Respir J. 2011;37(1):201-204.
55. Canakis AM, Cutz E, Manson D, O'Brodovich H. Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am J Respir Crit Care Med. 2002;165(11):1557-1565. (Pubitemid 34606674)
56. Deutsch GH, Young LR. Histologic resolution of pulmonary interstitial glycogenosis. Pediatr Dev Pathol. 2009;12(6):475-480.
57. Onland W, Molenaar JJ, Leguit RJ, et al. Pulmonary interstitial glycogenosis in identical twins. Pediatr Pulmonol. 2005;40(4):362-366. (Pubitemid 41437616)
58. Stankiewicz P, Sen P, Bhatt SS, et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet. 2009;84(6):780-791.
59. Sen P, Thakur N, Stockton DW, Langston C, Bejjani BA. Expanding the phenotype of alveolar capillary dysplasia (ACD). J Pediatr. 2004;145(5):646-651. (Pubitemid 39440944)
60. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277-304.